Annexin Pharmaceuticals AB (publ)
ANNX BTA SE0021148707
ICB 2010 : Health Care / Health CareSweden 111 60
SE-AB Stockholm KAMMAKARGATAN 48
Annual Performance 1
2023 | 2024 | 2025 |
---|---|---|
13% | 89% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 1 Insiders: 1
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Nils Anders Haegerstrand CEO |
0.20 SEK |
635,008 Bought |
127,002 SEK |
19/12/2023 | 18/12/2023 |